Amibegron
Amibegron
Amibegron (pronounced: /æmɪˈbɛɡrɒn/) is a pharmaceutical drug that is primarily used in the treatment of overactive bladder (OAB). It is a beta-3 adrenergic agonist, which means it works by activating receptors in the bladder to help control the urge to urinate.
Etymology
The term "Amibegron" is derived from the combination of the prefix "Ami-", which is often used in the naming of pharmaceutical drugs, and "-begron", which is a common suffix used in the naming of beta-3 adrenergic agonists.
Related Terms
- Pharmaceutical drug: A chemical substance used to treat, cure, prevent, or diagnose a disease or to promote well-being.
- Overactive bladder: A condition where the bladder can't hold urine normally.
- Beta-3 adrenergic agonist: A class of drugs that are primarily used for the treatment of overactive bladder.
See Also
- Mirabegron: A similar beta-3 adrenergic agonist used in the treatment of overactive bladder.
- Pharmacology: The branch of medicine that deals with the uses, effects, and modes of action of drugs.
External links
- Medical encyclopedia article on Amibegron
- Wikipedia's article - Amibegron
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski